UICC signs MoU on behalf of the ATOM Coalition to improve access to essential cancer medicines in Mongolia

The Memorandum of Understanding, reached with the support of National Cancer Council of Mongolia, bolsters the national strategy to enhance the availability of quality-assured oncology medicines.

Dr Tsetsegsaikhan Batmunkh (second from right), CEO of the National Cancer Council Mongolia with Dr Dan Milner (far left), Executive Director of the ATOM Coalition, with Sumi Krishnamurthy (far right), consultant with the ATOM Coalition and staff from the National Cancer Council Mongolia.

UICC is delighted to announce that it has signed a Memorandum of Understanding (MoU) with the Ministry of Health in Mongolia on behalf of the Access To Oncology Medicines (ATOM) Coalition, an initiative launched by UICC with some 40 partners across the private and civil society sectors, has signed

The MoU represents an important step towards improving access to and the availability of quality-assured cancer medicines within the country.

"The invaluable support of UICC member, the National Cancer Council of Mongolia, alongside other key national stakeholders such as the Medical Devices Regulatory Agency and the Pharmaceutical Association, played a crucial role in reaching this significant milestone."
– Dan Milner, Executive Director of the ATOM Coalition

The ATOM Coalition, with the support of UICC and in close collaboration with the Ministry of Health and local partners, is now focused on implementing strategies that will facilitate better access to essential oncology medicines. An immediate priority in this endeavour is the appointment of a country representative to efficiently coordinate the coalition's activities across Mongolia.

Tags National Cancer Council of Mongolia ATOM Coalition Access to Medicines

Last update

Wednesday 06 November 2024

Related content

Collage of different faces and people smiling

The UICC-led Access to Oncology Medicines (ATOM) Coalition has launched its first series of Health Financing Case Studies, providing insights into how low- and lower-middle-income countries (LLMICs) are financing cancer care – and where targeted adjustments can strengthen access to essential medicines and diagnostics.

Cary Adams, CEO of UICC presenting at the ATOM Coalition side event. A conference room filled with attendees seated in rows, facing a speaker at the front. The room features large windows allowing natural light, and a presentation screen displaying a colorful slide. The audience appears engaged, with a mix of individuals in business attire, some taking notes or looking at their devices. The setting has a modern design with wooden paneling and a professional atmosphere.

Marking three years of progress, UICC-led Access to Oncology Medicines (ATOM) Coalition reflects on key milestones expanding access to cancer medicines in low- and lower middle-income countries (LLMICs).